Approval · Notice of Compliance 31316 · 2023
IMDUR: Notice of Compliance 31316
Issued July 27, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31316
- Date
- July 27, 2023
- Company
- Juno Pharmaceuticals Corp.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site of the drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMDUR | Not yet assigned | — |
Medicinal ingredients
- ISOSORBIDE-5-MONONITRATE 60 MG per TAB